Introduction {#s1}
============

Regeneration occurs in widespread contexts and species. Invertebrates such as *Hydra* are capable of whole-animal regeneration from tissue fragments, and many vertebrates can regenerate appendages or repair damaged organs ([@bib31]). Despite this widespread relevance, the central mechanisms that drive regeneration are poorly understood.

Planarians are flatworms capable of regeneration following an almost limitless variety of injuries and have emerged as a powerful model for exploring the molecular underpinnings of regeneration ([@bib18]). New tissues are formed at planarian wound sites in a process called blastema formation, and pre-existing tissues are reorganized after amputation to accommodate reduced animal size and further generate missing tissues ([@bib15]; [@bib23]). The source of regenerated tissue in planarians is a population of adult dividing cells called neoblasts ([@bib23]), which include pluripotent stem cells called clonogenic neoblasts (cNeoblasts) ([@bib35]). Neoblasts are the only somatic cycling cells in adult animals and can be specifically ablated by gamma irradiation, allowing for dissection of the requirements for neoblasts in regenerative processes ([@bib23]). Recent work has described the earliest molecular and cellular events that occur following injury ([@bib21]; [@bib36]; [@bib32]; [@bib37]). One finding to emerge from this work is that animals initiate distinct cellular and molecular responses to 'major injuries' that remove significant amounts of tissue (e.g., head amputation) and to 'simple injuries' that require only minimal healing for repair (wounds that do not elicit blastema formation, such as punctures or incisions). Following simple injury, for example, animals display an increase in mitotic numbers 6 hr after injury before returning to baseline levels ([@bib36]), and expression of numerous wound-induced genes becomes undetectable by 24 hr after injury ([@bib37]). Following a major injury, these same initial responses are observed, but subsequent responses are also activated: the 6 hr increase in mitotic numbers is followed by a second increase 48 hr after amputation ([@bib36]), and wound-induced gene expression persists beyond 24 hr and is refined over several days ([@bib37]). These responses are referred to as the 'missing-tissue response' ([@bib36]; [@bib37]). How animals distinguish between injuries involving varying amounts of tissue loss and regulate these distinct wound response programs remains unknown.

We identified *Smed-follistatin* as required for molecular and cellular 'missing-tissue' responses during regeneration. Specifically, Follistatin-mediated inhibition of Activin signaling is required for regeneration to occur, with *Smed-follistatin* expression at wounds controlled by the extent of tissue absence following injury. These results suggest a mechanism by which regenerative responses can be initiated.

Results {#s2}
=======

*Smed-follistatin* is a wound-induced gene required for regeneration {#s2-1}
--------------------------------------------------------------------

To identify genes mediating regeneration-specific wound responses, we inhibited recently identified wound-induced genes ([@bib37]) with RNA interference (RNAi). Inhibition of *Smed-follistatin* (*follistatin* or *fst*), a gene encoding a Follistatin-like TGF-β-superfamily inhibitor, completely blocked regeneration ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). No brain regeneration or anterior pole regeneration was observed in *fst(RNAi)* animals ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). The anterior pole phenotype is consistent with a described role for *follistatin* in anterior regeneration ([@bib27]). *fst(RNAi)* animals, however, also failed to produce a blastema following either tail amputation or the excision of lateral tissue wedges that left anterior and posterior poles intact ([Figure 1B](#fig1){ref-type="fig"}). These data demonstrate that *fst* is required broadly for regeneration.10.7554/eLife.00247.003Figure 1.*fst* is wound induced and required for regeneration.(**A**) *fst(RNAi)* animals did not form blastemas after amputation (left, arrowheads, n \> 100) and did not regenerate a brain as assayed with an RNA probe for *choline-acetyltransferase* (*chat*, middle, arrowhead, n = 9/9). (**B**) *fst(RNAi)* animals did not form blastemas 8 days following excision of a wedge of lateral tissue (arrowhead, n = 14/14). (**C**) *fst(RNAi)* animals displayed no phenotype in the absence of amputation (right, n = 30/30, 123 days RNAi). (**D**) *fst(RNAi)* animals still produced new neurons 20 days after failing to regenerate (n = 8/8; cells that are SMEDWI protein^+^ and *chat*^*+*^ are newly differentiating neurons \[[@bib35]\]), demonstrating ongoing tissue turnover in old tissues. Scale bar 10 µm. (**E**) *fst* was expressed sparsely throughout the intact animal and at the anterior pole. Following head and tail amputation, robust *fst* expression occurred at both anterior and posterior wound sites, with peak expression 12 hr post-amputation. Scale bars = 100 µm for left of (**A**), (**B**), and (**C**); 200 µm for right of (**A**) and (**E**). Anterior up.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.003](10.7554/eLife.00247.003)10.7554/eLife.00247.004Figure 1---figure supplement 1.Specificity of the *fst* RNAi phenotype.Animals injected with dsRNA corresponding to non-overlapping sequences from either the 5′ half or the 3′ half of the *fst* gene failed to regenerate (n = 6/14 and 4/16 normal, respectively, compared to 16/16 normal for control), day 8. Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.004](10.7554/eLife.00247.004)10.7554/eLife.00247.005Figure 1---figure supplement 2.Anterior pattern defects in *fst(RNAi)* animals.*fst(RNAi)* animals displayed normal anterior *sfrp-1* expression 24 hr after amputation (n = 11/11, top), but by 8 days displayed none (n = 11/12, middle). *fst(RNAi)* animals also failed to regenerate anterior *ndk* expression (bottom, n = 7/8). Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.005](10.7554/eLife.00247.005)10.7554/eLife.00247.006Figure 1---figure supplement 3.Efficacy of *fst* RNAi.*fst* expression was reduced both prior to and following amputation in animals treated with *fst* dsRNA as assayed by quantitative PCR (qPCR). For qPCR, total RNA was isolated from asexual *Schmidtea mediterranea* animals, and cDNA was prepared using SuperScript III (Invitrogen) with oligo-dT primers. qPCR was performed using SYBR Green (Applied Biosystems), and data were normalized to the expression of *clathrin* as previously described ([@bib39]). *fst* (left: CCAGGCGAAAGAAATCCAG and right: GAGGTGGGGCATTTGATACA) primers were used to evaluate expression.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.006](10.7554/eLife.00247.006)10.7554/eLife.00247.007Figure 1---figure supplement 4.Wound-induced *fst* expression persists for several days after amputation.*fst* is expressed at wound sites throughout regeneration, with additional expression in the brain at later timepoints (arrows, 6 days and 8 days). Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.007](10.7554/eLife.00247.007)10.7554/eLife.00247.008Figure 1---figure supplement 5.*fst* is required after amputation for normal regeneration.Animals were amputated and injected four times with 30 nl *fst* dsRNA immediately after amputation and a second time 6 hr after amputation. Animals injected with *fst* dsRNA developed aberrant brains as labeled by *chat* expression, and in some cases produced no blastemas (n = 7/10 aberrant, 1/10 no blastema), while animals injected with control dsRNA regenerated normally (10/10 normal). Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.008](10.7554/eLife.00247.008)

Planarians constantly maintain adult tissues through cell turnover involving neoblasts ([@bib23]). Consequently, most genes required for regeneration are also required for tissue turnover because of an involvement in neoblast biology ([@bib24]). Strikingly, unamputated *fst(RNAi)* animals did not shrink or lose structures, as is typically seen in animals with neoblast dysfunction, even after several months of significant expression reduction with RNAi ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Furthermore, amputated animals---despite failing to regenerate---displayed ongoing long-term neoblast-based tissue turnover of remaining tissue ([Figure 1D](#fig1){ref-type="fig"}). Together, these data suggest that the requirement for *fst* in tissue replacement is specific to regeneration, as it is not detectably required for neoblast-mediated tissue turnover. Because of the rarity of genes required for regeneration but not tissue turnover, *fst* was a good candidate for specifically mediating the processes that occur following injury to bring about regeneration.

*fst* expression was induced at wounds by 6 hr following amputation ([@bib37]; [@bib27]) and persisted for several days, with maximal expression around 12 hr post-amputation ([Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). In unamputated animals, *fst* was expressed sparsely throughout the animal, including ventrally, in a thin peripheral domain, and at the anterior pole ([Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}; [@bib27]). Injection of *fst* dsRNA only after amputation caused poor blastema formation and regeneration defects ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}), consistent with a requirement for wound-induced *fst* expression in regeneration. We conclude that *fst* is a wound-induced factor required for regeneration.

*follistatin* is required for the regeneration-specific neoblast response {#s2-2}
-------------------------------------------------------------------------

To characterize the defects underlying regeneration failure in *fst(RNAi)* animals, we first investigated whether *fst* regulates neoblast function in regeneration. Neoblasts can be visualized by detecting neoblast-specific transcripts through whole-mount in situ hybridization ([@bib25]) and quantified using flow cytometry ([@bib3]). *fst(RNAi)* animals displayed normal neoblast numbers prior to amputation, indicating that the observed regeneration failure is not caused by neoblast loss ([Figure 2A](#fig2){ref-type="fig"}). We next assessed whether neoblasts respond to injury in *fst(RNAi)* animals. The neoblast response to injury involves two peaks (6 hr and 48 hr post-amputation) in mitotic cell numbers, in between which neoblasts migrate to wounds ([@bib36]). The first peak is generically induced by all injury types and is spatially widespread ([@bib36]). The second peak occurs specifically following major injuries (removing tissues) and is biased toward wound sites ([@bib36]). Amputated *fst(RNAi)* animals displayed a normal 6 hr mitotic peak, indicating that a normal generic injury response was present ([Figure 2B](#fig2){ref-type="fig"}). By contrast, these animals failed to display a 48 hr mitotic peak ([Figure 2B](#fig2){ref-type="fig"}). *fst(RNAi)* animals did however display localization of mitoses toward wound sites 48 hr after amputation ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), and neoblast enrichment at wound sites 18 hr after injury ([Figure 2C](#fig2){ref-type="fig"}), indicating that neoblast migration occurred normally.10.7554/eLife.00247.009Figure 2.*fst* is required for the neoblast response to missing tissue.(**A**) *fst* RNAi did not affect neoblast number or distribution as assayed with an RNA probe for *smedwi-1* (n = 5/5) and flow cytometry (percentage of live cells that were X1 cells). (**B**) *fst(RNAi)* tail fragments displayed reduced mitoses 48 hr and 72 hr after amputation (right, p\<0.01 and p\<0.001, two-tailed *t*-test). (**C**) Neoblasts migrated to wounds in *fst(RNAi)* animals as assayed for the presence of *smedwi-1*^+^ cells at wounds (*NB.21.11E*^*+*^ cells mark pre-existing tissue). (**D**) *fst(RNAi)* animals lacked eye progenitors following head amputation as assayed with RNA probes for *ovo*^+^/*smedwi-1*^+^ cells (p\<0.001, two-tailed *t*-test). Scale bars = 100 µm. Anterior up.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.009](10.7554/eLife.00247.009)10.7554/eLife.00247.010Figure 2---figure supplement 1.Neoblasts migrate to wounds normally in *fst(RNAi)* animals.Mitoses were enriched toward wound sites 48 hr after amputation in *fst(RNAi)* animals but were fewer in number (bottom right, p\<0.001 at 200 µm, two-tailed *t-*test).**DOI:** [http://dx.doi.org/10.7554/eLife.00247.010](10.7554/eLife.00247.010)

Given that *fst(RNAi)* animals displayed a defective proliferative response to missing tissue, we tested whether these animals produced regenerative progenitor cell types. Head amputation normally induces neoblasts to produce *ovo*^+^ eye progenitors ([@bib10]), but this process failed in *fst(RNAi)* animals ([Figure 2D](#fig2){ref-type="fig"}). From these data taken together, we conclude that *fst* is required for several aspects of the regeneration-specific neoblast response to injury.

*follistatin* is required for responding to tissue absence following injury {#s2-3}
---------------------------------------------------------------------------

The abnormal missing-tissue-specific mitotic response of *fst(RNAi)* animals raised the possibility that other missing tissue responses could also require *fst*. Apoptosis increases following injury in planarians ([@bib21]), and, like the mitotic response, this increase involves a generic injury phase and a missing-tissue-specific phase. First, a local apoptosis burst occurs at wound sites 4 hr following any injury; second, a body-wide apoptosis burst occurs 72 hr after injury, but only in cases involving missing tissue ([@bib21]). The apoptosis level in this latter phase scales with the amount of missing tissue ([@bib21]). Planarians possess a centrally located pharynx used for feeding and defecation ([@bib23]); measuring apoptotic cell numbers by TUNEL within the pharynx is an established assay for quantifying the body-wide increase in apoptosis that occurs 72 hr post-amputation ([@bib21]). Strikingly, *fst(RNAi)* pharynges displayed little increase in apoptotic cell numbers 72 hr post amputation, whereas a roughly 20-fold increase from pre-amputation levels occurred in control pharynges ([Figure 3A](#fig3){ref-type="fig"}). *fst(RNAi)* animals had a normal 4 hr apoptosis burst, indicating that *fst* is not generally required for apoptosis ([Figure 3B](#fig3){ref-type="fig"}). The 72 hr apoptotic response occurs in animals that have had their neoblasts ablated and cannot regenerate ([@bib21]). Therefore, the failure of *fst(RNAi)* animals to produce this response cannot be explained as a non-specific result of regeneration failure.10.7554/eLife.00247.011Figure 3.*fst* is required broadly for missing-tissue responses and morphallaxis.(**A**) *fst(RNAi)* animals displayed no increase in pharyngeal TUNEL^+^ cells 3 days post-amputation (p\<0.001, two-tailed *t*-test). Dotted white line = pharynx outline. (**B**) *fst(RNAi)* tail fragments displayed normal TUNEL^+^ cell numbers 4 hr post-amputation (n = 6/6). (**C**) *fst(RNAi)* animals displayed normal wound-induced gene expression 3 hr and 6 hr after amputation (*jun-1*: n = 20/20, *nlg1*: n = 5/5) but reduced expression compared to controls 24--48 hr after amputation (arrows; *jun-1*: 17/19 correctly scored blindly, p\<0.01 Fisher's exact test, *nlg1*: 22/27 correctly scored blindly, p\<0.01, Fisher's exact test). (**D**) *fst(RNAi)* animals had increased wound-induced expression of *delta-1* 24 hr after amputation (n = 12/12). (**E**) *fst(RNAi)* animals did not rescale expression of *wntP-2* 48 hr after amputation (n = 18/21). (**F**) *fst(RNAi)* animals did not reduce the number of *cintillo*^+^ cells in head fragments following amputation (p\<0.001, two-tailed *t*-test). Scale bars = 100 µm. Anterior up in (**A**--**C**), (**E**), (**F**). Anterior left in (**D**).**DOI:** [http://dx.doi.org/10.7554/eLife.00247.011](10.7554/eLife.00247.011)10.7554/eLife.00247.012Figure 3---figure supplement 1.The *fst(RNAi)* phenotype is not a non-specific result of regeneration failure.Left: Following lethal irradiation and amputation, animals displayed higher expression of *nlg1*, lower expression of *jun-1*, and higher expression of *delta-1* (n \> 5 for each). *smad1(RNAi)* animals did not form blastemas but displayed normal *delta-1* expression. Right: control tail fragments produced a pharynx de novo by 8 days after amputation, while *fst(RNAi)* tail fragments did not (arrowhead, n = 6/7). *smad1(RNAi)* animals failed to produce blastemas following amputation (arrowhead) but produced a pharynx normally (n = 5/5). The marker *madt* labels intestine and outlines pharynx (white area). Anterior up. Scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.012](10.7554/eLife.00247.012)

In addition to the cellular responses to missing tissue described above, persistence of wound-induced gene expression is another aspect of the planarian missing-tissue response ([@bib37]). We observed less expression of two wound-response genes in *fst(RNAi)* animals than in controls 24--48 hr post-amputation, despite expression levels being indistinguishable at earlier timepoints ([Figure 3C](#fig3){ref-type="fig"}). Notably, some wound-induced genes display expression that inversely scales with missing tissue amount; for example, *Smed-delta-1* displays higher expression after an incision or puncture (simple injuries) than after amputation (a major injury) ([@bib37]). Amputated *fst(RNAi)* animals displayed a higher, rather than lower, level of *Smed-delta-1* expression than did controls 24 hr after amputation ([Figure 3D](#fig3){ref-type="fig"}). Therefore, the lower expression levels observed for other wound-induced genes in *fst(RNAi)* animals do not reflect generically lower gene expression at wounds, but instead a specific requirement for *fst* for missing-tissue-specific gene expression.

Irradiated animals (which cannot regenerate) can display either higher or lower levels of wound-induced expression, depending on the gene examined ([@bib37]). Indeed, some wound-induced genes were similarly affected between irradiated and *fst(RNAi)* animals, while others were oppositely affected ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). As was the case for the failed apoptotic response of *fst(RNAi)* animals, the missing-tissue gene expression defects of *fst(RNAi)* animals cannot therefore be explained as a side-effect of regenerative failure.

In addition to producing a regeneration blastema, amputated animals must reorganize and rescale remaining tissue in a process termed morphallaxis ([@bib15]; [@bib23]). Some aspects of this process do not require blastema formation. For example, *wntP-2* (also known as *wnt11-5* \[[@bib2]\]) is normally expressed in planarian tails ([@bib22]; [@bib2]) and its expression domain restricts posteriorly within 48 hr of amputation whether regeneration proceeds or not ([@bib2]). *fst(RNAi)* animals did not rescale the *wntP-2* expression domain 48 hr following amputation, further supporting a model in which *fst* is required for responding to missing tissue ([Figure 3E](#fig3){ref-type="fig"}). Following head amputation, head fragments not only produce posterior-specific cell types but also reduce numbers of anterior-specific cell types (which are overabundant for the new fragment dimensions). This process failed in *fst(RNAi)* head fragments ([Figure 3F](#fig3){ref-type="fig"}). Finally, *fst(RNAi)* fragments did not produce pharynges de novo (which normally occurs in pre-existing head and tail fragment tissue) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). By contrast, RNAi of a different gene that blocked blastema formation (*smad1*) did not block pharynx formation, indicating this defect is not a simple consequence of blastema formation failure ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We conclude that *fst* is required broadly for missing-tissue-specific wound responses, and that these defects likely underlie the inability of *fst(RNAi)* animals to regenerate.

*Smed-activin-1* is required for the *follistatin* regeneration phenotype {#s2-4}
-------------------------------------------------------------------------

Because Follistatin proteins are well-characterized extracellular inhibitors of TGF-β ligands ([@bib17]; [@bib4]), we sought to identify putative TGF-β ligands that Smed-Follistatin might regulate to promote regeneration. Seven putative TGF-β superfamily members exist in the *Schmidtea mediterranea* genome ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [@bib13]; [@bib19]; [@bib26]; [@bib1]; [@bib14]; [@bib37]; [@bib27]). If Fst regulates one of the proteins encoded by these genes, then RNAi of that gene might suppress the *fst* RNAi phenotype. We tested this possibility (see [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"} and 'Materials and methods' for details) and found that RNAi of either of two genes, *Smed-activin-1* (*act-1* in short) or *Smed-activin-2* (*act-2*), strongly suppressed the blastema formation defect ([Figure 4A](#fig4){ref-type="fig"}), the failure to regenerate a brain ([Figure 4A](#fig4){ref-type="fig"}), and the failed missing-tissue apoptotic response of *fst(RNAi)* animals ([Figure 4B](#fig4){ref-type="fig"}); RNAi of *act-2* can also restore anterior pole regeneration in *fst(RNAi)* animals ([@bib27]). Given that Follistatin proteins can directly regulate Activin proteins in other organisms ([@bib17]; [@bib4]), these data suggest that Follistatin promotes missing tissue responses by inhibiting the function of Activin proteins.10.7554/eLife.00247.013Figure 4.*act-1* and *act-2* are required for the *fst* RNAi phenotype.(**A**) *fst(RNAi)* animals treated with control dsRNA did not produce blastemas or a brain after amputation (n = 17/22), whereas *fst(RNAi)* animals treated with *act-1* or *act-2* dsRNA produced normal blastemas and brain (*act-1*: n = 19/23, p\<0.0001; *act-2*: n = 16/26, p\<0.001; Fisher's exact test for both). Inhibition of other candidate genes did not suppress the *fst* RNAi phenotype (n \> 9 for all other conditions). Aberrant animals were scored as having greatly decreased or absent brain. (**B**) *fst(RNAi)* animals treated with control dsRNA displayed a reduced apoptotic response 3 days after amputation, whereas *fst(RNAi)* animals treated with *act-1* dsRNA displayed a normal apoptotic response (p\<0.001 between control RNAi and *fst*;*ctrl* RNAi; p\<0.01 between *fst*;*ctrl* RNAi and *fst*;*act-1* RNAi, two-tailed *t*-test for both). (**C**) *act-1(RNAi)* animals displayed a greater induction of *ovo*^+^ eye progenitors compared to controls 2 days after head amputation (n = 24, p\<0.0001, two-tailed *t*-test). Scale bars = 100 µm. Anterior up.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.013](10.7554/eLife.00247.013)10.7554/eLife.00247.014Figure 4---figure supplement 1.Phylogeny of planarian *activin* homologs.The *Smed-act-1* sequence was aligned with other TGF-β sequences using CLUSTALW ([@bib40]; [@bib41]). The alignments were trimmed using GBlocks ([@bib42]), allowing for smaller final blocks, gap positions within the final blocks, and less strict flanking positions. Bayesian analysis was performed using MrBayes ([@bib43]; [@bib44]). The Bayesian inference tree is shown with support values above 0.5 for each branch. Smed-Act-1 and Smed-Act-2 are shown in red. The phylogenetic positions of Smed-Act-1 and Smed-Act-2 support orthology with Activin proteins. Xl = *Xenopus laevis*, Mm = *Mus musculus*, Hs = *Homo sapiens*, Gg = *Gallus gallus*, Bf = *Branchiostoma floridae*, Dm = *Drosophila melanogaster*, Dr = *Danio rerio*, Sm = *Schmidtea mediterranea.***DOI:** [http://dx.doi.org/10.7554/eLife.00247.014](10.7554/eLife.00247.014)10.7554/eLife.00247.015Figure 4---figure supplement 2.RNAi controls for *fst* suppression experiments.Left: Animals treated with both *fst* dsRNA and *act-1* dsRNA display no *fst* RNAi phenotype even though expression of *fst* is greatly reduced (top). Animals treated with both *fst* dsRNA and *act-2* dsRNA displayed a similar reduction of the *fst* RNAi phenotype even though expression of *fst* is greatly reduced (bottom). Animals treated with *fst* dsRNA and another candidate dsRNA display the *fst* RNAi phenotype even though expression of candidate genes are greatly reduced (n \> 6 for all). Anterior left, scale bars = 100 µm. Right: *fst* expression was reduced in *fst(RNAi)* animals concomitantly treated with control dsRNA or with *act-1* dsRNA as assayed by quantitative PCR (performed as described in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) with two independent sets of *fst* primers (primer set 2 = left: TGGTGTGCAATTTAGCGAGT; right: ATTCACTGCAGCCTCTTGTG).**DOI:** [http://dx.doi.org/10.7554/eLife.00247.015](10.7554/eLife.00247.015)10.7554/eLife.00247.016Figure 4---figure supplement 3.Efficacy of *act-1* RNAi.*act-1* expression was reduced in *act-1(RNAi)* animals both prior to and 24 hr after amputation as assayed by quantitative PCR. qPCR was performed as described in [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}. *act-1* (left: GCGAGCTACCTTTCAATGCT, right: ACGGGAGTGCAACAGTTTTT) primers were used to evaluate expression.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.016](10.7554/eLife.00247.016)10.7554/eLife.00247.017Figure 4---figure supplement 4.*act-1(RNAi)* animals appear normal following regeneration.*act-1(RNAi)* animals formed blastemas and regenerated following head and tail amputation (n \> 200). Scale bars = 100 µm, anterior up.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.017](10.7554/eLife.00247.017)10.7554/eLife.00247.018Figure 4---figure supplement 5.*act-1(RNAi)* animals display normal neoblast numbers.Intact *act-1*(RNAi) animals displayed normal numbers of X1 cells as counted by flow cytometry.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.018](10.7554/eLife.00247.018)

*activin-1(RNAi)* animals display excessive progenitor production following amputation {#s2-5}
--------------------------------------------------------------------------------------

Given that *activin* expression is required for the *fst(RNAi)* phenotype, we investigated the consequences of *act-1* RNAi on regeneration. Although *act-2(RNAi)* has been reported to produce posterior regeneration defects ([@bib23]), *act-1(RNAi)* animals were capable of regenerating ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}, [Figure 4---figure supplement 4](#fig4s4){ref-type="fig"}) and, as with *fst(RNAi)*, displayed normal neoblast turnover during homeostatic growth ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}). *act-1(RNAi)* survived after amputation as well as controls did (observed more than a month following injury, n = 10/10). *act-1(RNAi)* animals did however display some abnormalities. Although *act-1(RNAi)* animals displayed normal *ovo*^+^ eye progenitor numbers prior to amputation, increased numbers as compared to controls were present following amputation ([Figure 4C](#fig4){ref-type="fig"}). By contrast, *fst* RNAi caused the opposite phenotype of reduced *ovo*^+^ eye progenitor formation. These data raise the possibility that *act-1* regulates responses to injury, with some aspects of regeneration overactive following *act-1* inhibition.

The amount of missing tissue regulates *follistatin* expression following injury {#s2-6}
--------------------------------------------------------------------------------

Because *fst* is required for regeneration but not for normal tissue turnover, we reasoned that *fst* expression might be high following amputation, an injury type requiring significant tissue regeneration, but low following incision or puncture, injuries requiring only wound healing. We therefore assessed *fst* as compared to *act* expression at wounds following either incision or excision of a tissue wedge. Increased *act-1* expression was not detected following either type of wound, with expression detected throughout the intestine of uninjured animals, suggesting an intestinal source of Activin-1 protein ([Figure 5A](#fig5){ref-type="fig"}). *act-2* expression was similar to *act-1* in intact animals, but unlike *act-1* is wound-induced ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}; [@bib27]). Indeed, *act-2* was wound-induced following either incision or tissue wedge excision, with expression persisting for several days irrespective of injury severity ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). By contrast, *fst* expression was induced at both wound types by 6 hr after injury, but by 48 hr after injury was present only at wedge excision wound sites ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). These results indicate that *fst* expression persists longer at wounds that result in tissue absence. Furthermore, *fst* expression was greater at wounds involving a large amount of missing tissue (assessed at 48 hr) than at wounds with little missing tissue ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). Together, these data are consistent with a model in which wound-induced *fst* expression levels are regulated by the amount of missing tissue. In this model, *fst* promotes regenerative responses by inhibition of *act-1* and *act-2* following major injury ([Figure 5D](#fig5){ref-type="fig"}).10.7554/eLife.00247.019Figure 5.*fst* induction is regulated by tissue absence following injury.(**A**) *act-1* was expressed broadly throughout the intestine and was not induced by amputation. (**B**) *act-2* was expressed in the intestine and pharynx in intact animals and induced following amputation at wound sites (6 hr and 24 hr, arrows), eventually spreading throughout the body (48 hr, arrows). (**C**) Animals displayed wound-induced expression of *fst* 6 hr after either incision or tissue wedge removal, but expression persisted only in cases of tissue wedge removal (n \> 5, p\<0.01, white arrowheads = injury site). (**D**) A proposed genetic model for *fst* and *act-1/2* in regeneration. Wounds induce *fst* expression. If there is missing tissue following injury, *fst* induction is high, Act-1/2 signaling is inhibited, and regeneration-specific responses are initiated. If there is no missing tissue following injury, *fst* expression is low, Act-1/2 signaling is not inhibited, and regeneration-specific responses are repressed. Scale bars = 100 µm. Anterior up.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.019](10.7554/eLife.00247.019)10.7554/eLife.00247.020Figure 5---figure supplement 1.Wound-induced *act-2* expression persists for several days after amputation.*act-2* expression persisted at high levels throughout the animal during regeneration until at least 8 days after amputation. Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.020](10.7554/eLife.00247.020)10.7554/eLife.00247.021Figure 5---figure supplement 2.*fst* and *act-2* expression is negligible at wound sites prior to injury.Lateral, post-pharyngeal expression of *fst* and *act-2* is minimal prior to injury (*act-2* signal present is intestinal). Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.021](10.7554/eLife.00247.021)10.7554/eLife.00247.022Figure 5---figure supplement 3.The amount of missing tissue regulates wound-induced *fst* expression.*fst* expression was higher in level 48 hr after an amputation resulting in a large amount of missing tissue than after an amputation resulting in little missing tissue, as measured by quantifying fluorescent in situ hybridization signal intensity (p\<0.01, two-tailed *t*-test). Anterior up, scale bars = 100 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.00247.022](10.7554/eLife.00247.022)

Discussion {#s3}
==========

Regeneration initiation {#s3-1}
-----------------------

All long-living animals face the prospect of injury and require regenerative mechanisms. Planarians are an exceptional example of the regenerative potential of animals. Distinct cellular and molecular programs for responding to simple injury vs missing tissue exist in planarians. In the case of injuries involving substantial missing tissue, animals mount unique mitotic and apoptotic responses and produce an extended program of wound-induced gene expression ([@bib21]; [@bib36]; [@bib37]). These events represent the earliest described divergent behaviors following major injuries requiring regeneration vs simple injuries requiring only wound healing. A central question has therefore become how these distinct responses are mediated.

We identified a gene encoding a homolog of the TGF-β inhibitor, *follistatin*, that is required for regeneration and for regeneration-specific cellular and molecular responses to injury. Our data suggest that inhibition of Activin signaling by Fst is required for initiating a regenerative response at wounds following major injury. Finally, *fst* is wound-induced, with the level of *fst* expression persisting at high levels longer following a major injury than following a simple injury. We propose that wound-induced *fst* expression allows for regenerative responses to be initiated specifically as a consequence of tissue absence.

The nature of the planarian missing-tissue response {#s3-2}
---------------------------------------------------

*fst* is the first gene known to be required for regeneration-specific responses in planarians. Not all missing-tissue responses are abolished following *fst* inhibition, however. For example, neoblast migration to amputation sites occurred normally in *fst(RNAi)* animals, despite the absence of a normal proliferative response. Similarly, although expression of *act-1* and *act-2* are required for the *fst(RNAi)* phenotype, inhibition of *activin* expression in the absence of amputation does not affect homeostatic tissue turnover or induce a regeneration-like state, demonstrating that the suppression of Activin alone is not sufficient to induce missing-tissue responses. Therefore, some aspects of the missing-tissue response to injury require an as yet unknown 'missing-tissue' signal or signals that operate independently of *fst* and Activin signaling. Identifying and characterizing these processes will be important for understanding how the decision to mount a regenerative response occurs.

TGF-β signaling across regenerative contexts {#s3-3}
--------------------------------------------

Our findings describe a system in which suppression of Activin signaling is required for regeneration. The possibility therefore exists that Activin signaling may serve similar functions in other organisms. Indeed, TGF-β signaling has been implicated as a negative regulator of regeneration in a variety of contexts, including following partial hepatectomy ([@bib29]; [@bib8]; [@bib28]), in embryonic chick retinas ([@bib30]), in renal regeneration following ischemia/reperfusion injuries ([@bib9]), and for mouse skeletal muscle regeneration ([@bib38]). Given the relevance of these systems to human medicine, it will be important to investigate to what extent regenerative regimes recapitulate the mechanisms observed in planarians. Interestingly, a number of systems use TGF-β signaling to promote rather than suppress regeneration: TGF-β signaling is involved in axolotl limb and *Xenopus* tail regeneration ([@bib11]; [@bib5]), *activin* expression can be induced by wounding and exogenous TGF-β can speed healing in mammals ([@bib16]; [@bib6]; [@bib34]), TGF-β signaling can promote regeneration following mouse ear hole-punching ([@bib12]), and wound-induced *activin* promotes cell proliferation and migration following zebrafish fin amputation ([@bib7]). Despite these contextual differences, TGF-β signaling plays a major role in many forms of regeneration studied. Therefore, uncovering 'missing-tissue' signals in planarians, describing how these signals interact with Activin signaling, and identifying the key factors regulated by these signals will inform a broad understanding of core regenerative mechanisms.

Materials and methods {#s4}
=====================

Gene cloning {#s4-1}
------------

For RNA probes, genes were cloned into pGEM and amplified with T7-promoter-containing primers. For RNAi, genes were cloned into pPR244 as described ([@bib25]). *activin-1* was cloned with primers 5'-TCAACTGAAACGGAAGTTGG-3' and 5'-TGGTGGATCCTTACTTGCAG-3', *activin-2* with primers 5'-ACCAATTATGGCCAATCCAG-3' and 5'-CCGGCTAATTGTGAACAAAC-3', and *follistatin* with 5'-CACAAGAGGCTGCAGTGAAT-3' and 5'-CATTCAGAAGGCATTGTCCA-3'.

RNAi {#s4-2}
----

The control dsRNA for all RNAi experiments was *unc-22* from *Caenorhabditis elegans*. RNAi experiments were performed by feeding a mixture of liver and bacteria expressing dsRNA ([@bib24]). 20 ml of bacterial culture was pelleted and resuspended in 60 μl of liver. For *fst* and *act-1* RNAi regeneration experiments, animals were fed on day 0, day 4, day 8, and day 12, amputated on day 16/17 and either soaked for 6 hr in 1 µg/µl dsRNA (TUNEL experiments), soaked for 2 hr in dsRNA (gene expression experiments), or not soaked in dsRNA. For suppression experiments, totals from two separate experiments were pooled: (1) animals were fed *fst* dsRNA on day 0, day 4, day 8, and day 12, fed candidate gene dsRNA on day 16, day 20, and day 23, and amputated on day 24. (2) Animals were amputated and injected four times with a 30 nl equimolar mixture of *fst* and candidate gene dsRNA on day 0, injected without amputation on day 1, amputated and injected on day 4, and injected only on day 5. Animals were scored and fixed 8 days after the final amputation.

In situ hybridizations, immunostaining, and TUNEL {#s4-3}
-------------------------------------------------

Whole-mount in situ hybridizations and fluorescence in situ hybridizations (FISH) were performed as described ([@bib20]). For double/triple labeling, HRP-inactivation was performed between labelings (4% formaldehyde, 30 min). Immunostainings were performed as previously described ([@bib25]) using tyramide signal enhancement. TUNEL was performed as previously described ([@bib21]).

γ-irradiation {#s4-4}
-------------

For elimination of neoblasts, planarians were exposed to 6000 rad (6K, ∼72 min) using a cesium source (∼83 rad/min).

Flow cytometry {#s4-5}
--------------

Animals were amputated in cold CMFB, and cells prepared as described ([@bib33]). For quantification of X1 cells, five animals were used per RNAi condition in triplicate. Analyses and sorting were performed using a Moflo3 FACS sorter (Dako-Cytomation, Carpinteria, CA) and FlowJo.

Imaging and analyses {#s4-6}
--------------------

For quantifying cell numbers expressing a marker or an area of positive cells, equal numbers of optical stacks were taken per specimen, collapsed, and quantified using Automeasure in AxioVision (Zeiss, Jena, Germany) or manually. For quantification of fluorescence intensity, 7 optical stacks were acquired from the ventral surface of animals, collapsed, and values determined using the Automeasure module (Densitometric sum) in AxioVision (Zeiss). Images were acquired using an AxioImager with Apotome (Zeiss) or an LSM 700 (Zeiss).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elife.elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for choosing to send your work entitled "Tissue absence initiates regeneration through Follistatin-mediated inhibition of Activin signaling" for consideration at *eLife*. Your article has been evaluated by a Senior editor and 3 reviewers, one of whom, Marianne Bronner, is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments based on the reviewers\' reports. Our goal is to provide the essential revision requirements as a single set of instructions, so that you have a clear view of the revisions that are necessary for us to publish your work.

This is a thorough and interesting paper that makes an excellent contribution to the body of knowledge in this field. Gaviño, et al. demonstrate a novel role for the Activin branch of TGFβ signaling in planarian regeneration. The paper is potentially appropriate for *eLife* after the authors attend to the following concerns:

1\) The major findings revolve around two TGFβ family members, *follistatin* and *activin-1*, and their role in regeneration, effects on cell proliferation, etc. The story is interesting but fairly simple and straightforward. Therefore, the paper would be improved by significant shortening to concentrate on the major findings. The authors are encouraged to rewrite the paper in shorter format and reduce the number of figures accordingly.

2\) The interpretation that *activin-1(RNAi)* significantly speeds up the normal regenerative response is not convincing. An alternative interpretation is that the mechanisms regulating homeostasis and regeneration may have become uncoupled in *activin-1(RNAi)*. The increased *ovo* expression in animals 20 days after amputation is intriguing, suggesting that there is an elevated level of tissue homeostasis after a single round of RNAi and regeneration. Are there survival disadvantages for animals that have undergone long term *activin-1(RNAi)* coupled with amputation? The claim of speeding regeneration is semantic in nature and should be toned down.

3\) The authors argue that *activin* is upstream of *Smad4* by showing that *Smad4(RNAi)* causes an increase in apoptosis like *activin(RNAi)*. Since *Smad4(RNAi)* causes a profound regeneration defect, the apoptotic increase could be secondary to this defect. Furthermore, it has been shown that *activin* can signal independent of *Smad4* (Suzuki et al., Biochemical and biophysical research communications, 2010.) Are there any other upstream R-Smads capable of recapitulating the Activin defect or also rescue the Follistatin phenotype?

4\) The authors show adult homeostatic expression patterns for *follistatin* and *activin*, yet they have no apparent phenotype under homeostasis. One concern is that the RNAi conditions may not be effective enough to knock down these homeostatic levels of these factors. This would prevent them from making the conclusion that these factors have no effect normally. Activin especially seems like a good candidate to regulate the neoblast homeostatic niche. In order for the authors to conclude that knockdown of these factors has no effect in homeostasis, they should provide in situ data to demonstrate that the adult expression of these factors is indeed repressed by RNAi to a reasonable degree.

5\) The generic controls for RNAi seem inadequate. The authors should perform rescue experiments and lack of off-target effects.
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Author response

1*) The major findings revolve around two TGFβ family members*, follistatin *and* activin-1, *and their role in regeneration, effects on cell proliferation, etc. The story is interesting but fairly simple and straightforward. Therefore, the paper would be improved by significant shortening to concentrate on the major findings. The authors are encouraged to rewrite the paper in shorter format and reduce the number of figures accordingly*.

We have reworked the paper as suggested. We reduced the number of figures from seven to five, removing data from multiple experiments from the main figures. Focus is increased on the *follistatin* RNAi phenotype and we removed roughly 1/3 of the text from the manuscript.

*2) The interpretation that* activin-1(RNAi) *significantly speeds up the normal regenerative response is not convincing. An alternative interpretation is that the mechanisms regulating homeostasis and regeneration may have become uncoupled in* activin-1(RNAi). *The increased* ovo *expression in animals 20 days after amputation is intriguing, suggesting that there is an elevated level of tissue homeostasis after a single round of RNAi and regeneration. Are there survival disadvantages for animals that have undergone long term* activin-1(RNAi) *coupled with amputation? The claim of speeding regeneration is semantic in nature and should be toned down*.

We have simplified the manuscript and it now focuses more on the *follistatin* phenotype. With *activin* RNAi, we present suppression of the *follistatin* RNAi phenotype and increased *ovo+* progenitor presence at amputation sites. The issue of speeding regeneration will be a good target for future work.

We also investigated the long-term survival of *activin-1(RNAi)* animals following amputation as suggested. We found that there was not an increased level of animal death over the period observed (∼1 month) in *activin-1(RNAi)* animals as compared to controls. This is now referenced in the main text.

*3) The authors argue that* activin *is upstream of* Smad4 *by showing that* Smad4(RNAi) *causes an increase in apoptosis like* activin(RNAi)*. Since* Smad4(RNAi) *causes a profound regeneration defect, the apoptotic increase could be secondary to this defect. Furthermore, it has been shown that* activin*can signal independent of* Smad4 *(Suzuki et al., Biochemical and biophysical research communications, 2010.) Are there any other upstream R-Smads capable of recapitulating the Activin defect or also rescue the Follistatin phenotype*?

We removed the *smad4* phenotype from the manuscript, as we now are leaving the apoptosis responses to wounding in *activin* deficient animals for more detailed future work.

*4) The authors show adult homeostatic expression patterns for* follistatin*and* activin*, yet they have no apparent phenotype under homeostasis. One concern is that the RNAi conditions may not be effective enough to knock down these homeostatic levels of these factors. This would prevent them from making the conclusion that these factors have no effect normally. Activin especially seems like a good candidate to regulate the neoblast homeostatic niche. In order for the authors to conclude that knockdown of these factors has no effect in homeostasis, they should provide in situ data to demonstrate that the adult expression of these factors is indeed repressed by RNAi to a reasonable degree*.

We performed the RNAi controls in homeostatic conditions as suggested. We used quantitative PCR to measure *fst* expression levels in unamputated *fst(RNAi)* animals and also in *fst(RNAi)* fragments 24h after amputation. In these two cases, *fst* expression was inhibited by RNAi to a similar extent. We performed the same experiment in unamputated *activin-1(RNAi)* animals and 24h *activin-1(RNAi)* regenerating fragments. Here as well, expression was inhibited by RNAi to a similar degree in both contexts. These data are now included in [Figure 1--figure supplement 3](#fig1s3){ref-type="fig"} and [Figure 4--figure supplement 3](#fig4s3){ref-type="fig"}, respectively.

To further demonstrate that the effect of *fst* RNAi is specific to regeneration, we labeled amputated *fst(RNAi)* animals that had failed to regenerate with a combination of markers that identify differentiating neurons 20d after amputation. Strikingly, in these animals that produced no blastemas, new neurons were still being made in old tissues. Furthermore, irradiated animals (irradiation kills neoblasts and blocks tissue turnover) die within roughly 2 weeks of irradiation, whereas these amputated animals survive long-term despite failing to regenerate. These data demonstrate that *fst(RNAi)* animals that fail to produce new tissues at wound sites continue to replace aging cells for tissue turnover, indicating the specificity of requirement for fst under these experimental conditions for regeneration. These data are now included in [Figure 1](#fig1){ref-type="fig"}.

*5) The generic controls for RNAi seem inadequate. The authors should perform rescue experiments and lack of off-target effects*.

We performed and now present quantitative PCR experiments to measure the extent of both *fst* and *activin-1* inhibition by RNAi in unamputated and regenerating animals (see point 4 above).

Furthermore, (in addition to previously presented *in situ* controls) we measured the extent of *fst* and *activin-1* inhibition in *fst*; *activin-1* double RNAi animals and observed that *fst* is inhibited at least as strongly in these double RNAi animals as in *fst; control* double RNAi animals. These data are presented in [Figure 4--figure supplement 2](#fig4s2){ref-type="fig"}.

To address the specificity of *fst* RNAi, we produced two additional RNAi constructs for inhibiting *fst* expression, with each construct spanning a non-overlapping portion of the *fst* gene. Both of these constructs caused a regeneration phenotype. These data are now presented in [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}.

[^1]: These authors contributed equally to this work.
